Evaxion Biotech Reports Preclinical Proof of Concept Data for Evaxion's AI-powered Vaccine Platform RAVEN for the Design of a Next Generation SARS-CoV-2 VaccineGlobeNewsWire • 06/03/21
Evaxion Biotech A/S (EVAX) CEO Lars Wegner on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/14/21
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/13/21
Evaxion Biotech to Host Q1 2021 Corporate Update Conference Call & Webcast on May 13GlobeNewsWire • 05/06/21
Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to Optimize Cancer ImmunotherapyGlobeNewsWire • 04/20/21
Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 04/06/21
Evaxion Biotech to Host Full-Year 2020 Corporate Update Conference Call & Webcast on April 6GlobeNewsWire • 03/30/21
Evaxion Biotech Announces Publication of Study on S. aureus Bacterium in Scientific ReportsGlobeNewsWire • 03/16/21
Evaxion Biotech Closes its U.S. Initial Public Offering of American Depositary SharesGlobeNewsWire • 02/10/21